Item Posts Archive - Page 8 of 1770 - Medivizor
Navigation Menu

Evaluating the long-term effectiveness and safety of fixed-duration combination of ibrutinib plus obinutuzumab-based immunochemotherapy for patients with chronic lymphocytic leukemia.

Evaluating the long-term effectiveness and safety of fixed-duration combination of ibrutinib plus obinutuzumab-based immunochemotherapy for patients with chronic lymphocytic leukemia.

Posted by on Aug 27, 2023 in Leukemia | 0 comments

In a nutshell This study reported the long-term effectiveness and safety of the fixed-duration combination of ibrutinib (Imbruvica) plus obinutuzumab (Gazyva)–based immunochemotherapy for patients with previously untreated chronic lymphocytic leukemia (CLL). The data showed that a fixed-duration combination of ibrutinib plus obinutuzumab-based...

Read More

How safe and effective is prophylactic cranial irradiation in patients with extensive stage small cell lung cancer?

How safe and effective is prophylactic cranial irradiation in patients with extensive stage small cell lung cancer?

Posted by on Jul 30, 2023 in Lung cancer | 0 comments

In a nutshell This study evaluated the effectiveness and safety of prophylactic cranial irradiation (PCI) in patients with extensive stage (ES) small cell lung cancer (SCLC). The data indicated that PCI may decrease the occurrence of brain metastases in patients with ES-SCLC and improve 1-year survival time, without improving the overall survival...

Read More

Investigating the effectiveness of compression bandage applied with different pressures on the skin and subcutaneous tissue thickness in patients with breast cancer-related lymphedema

Investigating the effectiveness of compression bandage applied with different pressures on the skin and subcutaneous tissue thickness in patients with breast cancer-related lymphedema

Posted by on Jul 30, 2023 in Breast cancer | 0 comments

In a nutshell The study evaluated the effectiveness of compression bandages applied with different pressures on the skin and subcutaneous tissue in patients with breast cancer-related lymphedema (BCRL). The study concluded that high-pressure compression bandage was more effective in reducing skin and subcutaneous tissue thickness and inflammation in...

Read More

Evaluating the effectiveness and safety of polatuzumab vedotin combined with dose-adjusted EPOCH-R chemotherapy in patients with aggressive B-cell non-Hodgkin lymphoma.

Evaluating the effectiveness and safety of polatuzumab vedotin combined with dose-adjusted EPOCH-R chemotherapy in patients with aggressive B-cell non-Hodgkin lymphoma.

Posted by on Jul 30, 2023 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study evaluated the effectiveness and safety of polatuzumab vedotin (PV; Polivy) combined with dose-adjusted EPOCH-R chemotherapy (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in patients with aggressive B-cell non-Hodgkin lymphoma (NHL). The data showed that PV combined with dose-adjusted EPOCH-R...

Read More

Evaluating the effects of Baduanjin exercise on motor function, balance, and gait in patients with Parkinson’s disease.

Evaluating the effects of Baduanjin exercise on motor function, balance, and gait in patients with Parkinson’s disease.

Posted by on Jul 30, 2023 in Parkinson's Disease | 0 comments

In a nutshell This study evaluated the effects of Baduanjin exercise on motor function, balance, and gait in patients with Parkinson’s disease (PD). The data showed that Baduanjin exercise significantly improved motor function, balance, and gait in these patients. Some background PD is a disorder in which part of the brain is progressively...

Read More
ABOUT USHOW IT WORKSBLOG NEWS PARTNERS CONTACT US PRIVACY POLICY TERMS OF USE
FROM OUR BLOG
LATEST NEWS
CONNECT WITH US
© 2024 Medivizor